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HSV-1 can infect the skin or mucosa of both humans and experi-
mental animals where it undergoes local replication (Roizman and
Knipe, 2001). After entering sensory nerve endings, virus spreads via
retrograde axonal transport to the ganglia of the peripheral nervous
system (PNS) where a productive infection of neurons ensues
(Whitley, 2001). Although infectious virus is eventually cleared
from all sites, a latent infection of the PNS ganglia is established in a
number of neurons (Gilden et al., 2001; Stevens and Cook, 1971).
In contrast, HSV-1 infection of the CNS is less well understood. In
humans, virus is transmitted across synapses and latent virus is
reportedly widespread in the CNS (Baringer and Pisani, 1994; Itzakhi
et al., 1997). HSV-1 is also the commonest cause of fatal sporadic viral
encephalitis in man (Roos, 1999; Whitley et al., 1998) with mortality
rates reaching 20 to 30% despite treatment (Kennedy, 2005). In
experimental animals, HSV-1 can also cause latent infection of the
CNS (Rock and Fraser, 1983) and fatal encephalitis (Whitley, 2001).
Natural resistance to mortality following intraperitoneal (i.p.)challenge with HSV-1 is a dominant autosomal trait and dependent
on the inbredmouse strain (Lopez, 1975). Although, resistance to fatal
HSV-1 encephalitis is genetically complex and involves multiple
interacting loci (Lundberg et al., 2008), the herpes resistance locus
(Hrl) onmouse chromosome 6 has been identiﬁed as one determinant
of resistance (Lundberg et al., 2003) with TNF playing an important
role in mediating resistance (Lundberg et al., 2007). In mice
inoculated with HSV-1 via the oral mucosa, natural resistance is also
a dominant autosomal trait and mouse strain dependent (Kastrukoff
et al., 1986). In this study we used a combination of antibody depleted
and KO mice to examine the contribution of cellular immunity in
mediating resistance to HSV-1 encephalitis.
Results
HSV-1 spreads throughout the CNS in susceptible BALB/c but is
restricted to the brainstem in resistant BL/6 mice
To determine the extent of HSV-1 involvement of the CNS of
susceptible BALB/c and resistant BL/6 mice, 10–12 week ♀ mice
were infected with a sub-lethal dose of virus via the oral mucosa
(Kastrukoff et al., 1986). Viral titers were determined in the lip,
trigeminal ganglia (TG), and throughout the brain for up to 15 days
PI (Fig. 1). HSV-1 spreads throughout the brain in BALB/c mice
Fig. 1. Analysis of virus titers throughout the brains of 10–12 week ♀ BALB/c (A) and BL/6 (B) mice infected with a sub-lethal dose of HSV-1 via the oral mucosa. Each ﬁgure
represents results from ﬁve independent experiments; no.=10 mice/time point. *, Pb0.05 by unpaired two-tailed t test. Error bars represent SEM.
249L.F. Kastrukoff et al. / Virology 400 (2010) 248–258(Fig. 1A) but is restricted to the brainstem (BST) in BL/6 mice
(Fig. 1B) before being cleared in both mouse strains. Viral titers were
similar in the lip of both strains on day 1 PI but then increased in
BALB/c compared to BL/6 mice (∼10-fold) by day 3 PI. In the TG,
viral titers peaked in both mouse strains on day 3 PI but were
signiﬁcantly greater in BALB/c mice (∼100-fold). In the BST, viral
titers in BALB/c mice peaked on day 7 PI and again were
signiﬁcantly greater than in BL/6 mice. Infectious virus was ﬁrst
identiﬁed in the cerebellum/ cerebrum (CB/CR) of BALB/c mice on
day 4/5 PI and peaked on day 7/8 PI (Fig. 1A). Although infectious
virus was cleared from all sites by day 9 PI, clearance was delayed in
the TGandBST of BALB/c compared toBL/6mice. The reduced viral load
in the TG and BST of BL/6 compared to BALB/c mice, along with
restricted viral spread in the brain correlates with the natural resistance
to mortality of this strain, following infection of the oral mucosa with
HSV-1 (Kastrukoff et al., 1986).Fig. 2. Analysis of virus titers throughout the brains of 10–12 week ♀ B6.129S7-
Rag1tm1Mom/J (B6.RAG-1−/− KO) mice inoculated with a sub-lethal dose of HSV-1 via the
oral mucosa. The ﬁgure represents the results of ﬁve independent experiments; no.=10
mice/time point. Error bars represent SEM.HSV-1 spreads throughout the CNS of BL/6 RAG-1 KO (B6.RAG-1−/−)
mice
To determine if the immune system contributes to the restriction
of HSV-1 spread in the CNS of BL/6 mice, 10–12 week ♀ B6.129S7-
Rag1tm1Mom/J (B6.RAG-1−/− KO) mice (Mombaerts et al., 1992) were
infected with a sub-lethal dose of virus via the oral mucosa. These
mice are reported to be ten times more susceptible to infection with
HSV-1 then BL/6 mice (Vollstedt et al., 2004). Viral titers were
determined in the lip, TG, and throughout the brain for up to 15 days
PI. HSV-1 spreads throughout the brain of B6.RAG-1−/− KO mice
(Fig. 2). Viral titers in the lip, TG, and throughout the brain increased
steadily and virus was not cleared. Mice became ill by day 9 PI and all
succumbed to the infection by day 12 PI. The results support a role for
the immune system not only in restricting the spread but also in
clearing HSV-1 from the brains of BL/6 mice.NK/NKT cells do not restrict the spread of HSV-1 in the CNS but do
restrict viral replication in the oral mucosa of BL/6 mice during early
stages of infection
The importance of natural killer (NK) cells in HSV-1 infection
remains controversial (Pereira et al., 2001). To determine if they con-
tribute to restricting viral spread in the CNS, ten to twelve week♀ BL/6
mice received a total of 600 μg of PK136 mAb i.p. and a sub-lethal dose
of HSV-1 via the oralmucosa. Viral titers were determined in the lip, TG,
and throughout thebrain up to15 days PI (Fig. 3A). CD3−NK1.1+ cells in
the spleen were reduced by 85% on day 6 and by 84% on day 15 PI as
determined by ﬂow cytometry (data not shown). Comparable levels of
depletion with PK136 mAb are reported by other investigators (Postol
Fig. 3. Analysis of virus titers throughout the brains of 10–12 week BL/6 mice treated with anti-NK1.1 mAb (A) and inoculated with a sub-lethal dose of HSV-1 via the oral mucosa.
Viral titers throughout the brains of 10–12 week HSV-1 infected C57BL/6 CD1d-deﬁcient (B6.CD1d−/− KO) (B) and C57BL/6 NKT cell-deﬁcient (B6. TCR Jα281 KO) (C) mice were
also determined. All ﬁgures represent the results of ﬁve independent experiments; no.=10 mice/time point. *, Pb0.05 by unpaired two-tailed t test. Error bars represent SEM.
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BSTof PK136mAB treatedmicebyﬂowcytometry (datanot shown), the
total absence of these cells is difﬁcult to conﬁrm. A number of factors
contribute to this including: the small numbers of inﬂammatory cells in
the BST even prior to depletion, the viscosity of the homogenate which
interferes with the isolation of cells, the autoﬂuorescence of CNS cells
which interferes with ﬂow analysis, and receptor blockade resulting
from the pre-treatment of cells with anti-NK1.1 mAb. Despite deple-
tion of CD3−NK1.1+ cells, the spreadofHSV-1 in thebrains of BL/6mice
remained restricted to the BST.
In the lip, viral titers were similar in both mice treated with PK136
mAb and controls on day 1 PI but then increased signiﬁcantly in the
treated groupwith titers peaking on day 3 PI (∼1000-fold increase). In
the TG, viral titers were also increased in the treated group on day 3 PI
(∼100-fold) while in the BST, viral titers were not signiﬁcantly
different from controls. Virus was cleared from all sites by day 9 PI.
The role of invariant natural killer T (iNKT) cells in HSV-1 infection
also remains controversial (Grubor-Bauk et al., 2003; Cornish et al.,2006). Todetermine if they contribute to the restrictionof viral spread in
the CNS, ten to twelve week ♀ BL/6 CD1d-deﬁcient (B6.CD1d−/− KO)
(Mendiratta et al., 1997) and BL/6NKT cell-deﬁcient (B6.TCR Jα281KO)
(Cui et al., 1997)micewere infectedwith a sub-lethal dose of HSV-1 via
the oralmucosa. Viral titers in the lip, TG, and throughout the brainwere
determined up to 15 days PI in B6.CD1d−/− KO mice (Fig. 3B) and B6.
TCRJα281 KOmice (Fig. 3C). The spread of HSV-1 in the brains of these
mice remained restricted to the BST.
In the lip, viral titers were similar in CD1d-deﬁcient, NKT cell-
deﬁcient and control mice on day 1 PI but increased modestly in the
deﬁcient groups thereafter. Viral titers were ∼10 fold greater in the lip
and TG of deﬁcient mice compared to controls on day 3 PI. In the BST,
viral titers were not signiﬁcantly different in deﬁcient mice and
controls. Infectious virus was cleared from all sites by day 10 PI.
The results do not support a role for NK/NKT or iNKT cells in
restricting the spread of HSV-1 in the CNS of BL/6 mice. In contrast,
NK/NKT cells do contribute to the restriction of viral replication in the
lip and TG while iNKT cells may have a modest effect at these sites.
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viral replication in the oral mucosa and peripheral ganglia of BL/6 mice
during later stages of infection
CD8+ T-cells respond to HSV infection by cytokine production or
by direct killing of target cells (Bonneau and Jennings, 1989; Larsen
et al., 1983, 1984; Nash et al., 1987; Smith et al., 1994; Trapani and
Smyth, 2002). As protection against encephalitis has been reported to
be the primary domain of CD8+ T-cells (Newell et al., 1989; Simmons
and Nash, 1984; Simmons and Tscharke, 1992), we hypothesized
that anti-HSV CD8+ CTL might also be responsible for restricting
the spread of HSV-1 in BL/6 mice. Ten to twelve week ♀ BL/6 mice,
depleted of CD8+ cells, were infected with a sub-lethal dose of HSV-1
via the oral mucosa. Treatment with 2.43 mAb resulted in N95%
depletion of CD3+CD8+ spleen cells on days 3, 9, and 15 PI (data not
shown). Ten to twelve week♀ BL/6 CD8 KO (B6.129S2-Cd8atm1Mak/J)
(Fung-Leung et al., 1991) mice were also infected with a sub-lethal
dose of HSV-1. Viral titers were determined in the lip, TG, andFig. 4. Analysis of viral titers throughout thebrain of 10–12 week♀BL/6mice depleted of CD8+(
to twelveweek♀ B6.129S2-Cd8atm1Mak/J (B6.CD8KO) (B), B6.129-H2d1Ab1-Ea/J (B6.CL II KO) (D)
sub-lethal dose of virus. Each ﬁgure represents the results of ﬁve independent experiments; nothroughout the brain up to 15 days PI in depleted (Fig. 4A) and KO
(Fig. 4B) mice. In both groups of mice, the spread of HSV-1 remained
restricted to the BST.
In the lip and TG, viral titers increased in CD8+ depleted mice on
day 3 but peaked by day 6 PI (∼100-fold) compared to controls.
However, viral titers in the BST were not signiﬁcantly different in
depleted or control mice. Although infectious virus was cleared from
all sites by day 9 PI, viral clearance from the TGwas delayed compared
to controls (Fig. 4F).
Together, results from both depletion studies and KOmice support
a role for CD8+ T-cells in restricting viral replication in the lip and TG
but not in restricting the spread of HSV-1 in the brains of BL/6 mice.
These results are consistent with those of other investigators (Ghiasi
et al., 1999). Although the delay in viral clearance from the TG sup-
ports a role for these cells in the clearance of HSV-1, virus is cleared
from the lip and TG in both CD8+ T-cell depleted and KO mice. The
results suggest that redundancy in the immune system plays a role in
viral clearance at these sites.A)or CD4+ (C)T-cells and infectedwith a sub-lethal doseofHSV-1via theoralmucosa. Ten
, B6.129P2-Tcrdtm1Mom/J (B6.γδ T-cell KO) (E), and BL/6 (F)micewere also infectedwith a
.=10 mice/time point. *, Pb0.05 by unpaired two-tailed t test. Error bars represent SEM.
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restrict viral replication in the oral mucosa of BL/6 mice during later
stages of infection
CD4+ T-cells protect experimental animals from HSV infection
(Manicken and Rouse, 1995; Manicken et al., 1995a,b). To determine
if these cells might restrict the spread of virus in the CNS of BL/6mice,
ten to twelve week♀ BL/6mice, depleted of CD4+ cells, were infected
with a sub-lethal dose of HSV-1 via the oral mucosa. Treatment with
GK1.5 mAb resulted in N95% depletion of CD3+CD4+ spleen cells
on days 3, 9, and 15 PI (data not shown). Ten to twelve week ♀ BL/6
CL II KO (B6.129-H2d1Ab1-Ea/J) mice (Madsen et al., 1999) were also
infected with a sub-lethal dose of HSV-1. Viral titers were determined
in the lip, TG, and throughout the brain for 15 days PI in depleted
(Fig. 4C) and KO (Fig. 4D)mice. In both, the spread of HSV-1 remained
restricted to the BST.
In the lip, viral titers were similar in CD4 depleted, KO, and control
mice on day 1 PI but increased in depleted and KO mice; peaking on
day 6 PI (∼100-fold increase). However, viral clearance was delayed
in the lip and TG of depleted and KO mice compared to controls.
Together, the results from depletion studies and BL/6 CL II KO mice
support a role for CD4+ T-cells in restricting viral replication in the lip
along with clearing virus from the lip and TG but not in restricting the
spread of HSV-1 in the brain. The results are similar to reports by other
investigators (Ghiasi et al., 1999). Although these cells contribute to
the clearanceofHSV-1, virus is cleared from the lip and TGdespite CD4+
T-cell depletion and in CL II KO mice. The results suggest that redun-
dancy in the immune systemplays a role in viral clearance at these sites.
γδ T-cells do not restrict the spread of HSV-1 in the CNS of BL/6 mice
As virus speciﬁc γδ T-cells are identiﬁed in mice infected with
HSV-1 (Johnson et al., 1992; Sciammas et al., 1994), we investigated
the possibility that these cells restrict the spread of virus in the CNS
of BL/6 mice. Ten to twelve week ♀ BL/6 γδ T-cell KO (B6.129P2-
Tcrdtm1Mom/J) mice (Itohara et al., 1993) were infected with a sub-
lethal dose of HSV-1 via the oral mucosa. Viral titers were determined
in the lip, TG, and throughout the brain up to 15 days PI (Fig. 4E). The
spread of HSV-1 remains restricted to the BST in these mice.
This subset of immune cells appears to contribute little to
restricting viral replication in the lip, TG, or BST. However, they may
have a modest effect in the TG as the clearance of infectious virus is
delayed in these mice. Similar results were reported by Liu et al.
(1996) using a corneal inoculation model in A/J mice while Sciammas
et al. (1997) concluded that γδ T-cells could play a role in the TG
during acute HSV-1 infection.Fig. 5. Analysis of viral titers throughout the brain of 10–12 week♀ BL/6mice treated with b
mucosa. The ﬁgure represents the results of ﬁve independent experiments; no.=10 mice/HSV-1 remains restricted to the brainstem in BL/6 mice depleted of
CD4+ and CD8+ T-cells while infectious virus persists in the oral
mucosa, TG, and brainstem
Both CD8+ and CD4+ T-cells may be required for optimal pro-
tection against HSV infection (Howes et al., 1979; Nash et al., 1981).
To determine if both T-cell subsets are required to restrict the spread
of HSV-1 in the CNS of BL/6 mice, 10–12 week ♀ BL/6 mice, depleted
of CD8+ and CD4+ T-cells, were infected with a sub-lethal dose of
HSV-1 via the oral mucosa. Treatment with both GK1.5 and 2.43 mAbs
resulted in N95% depletion of CD3+CD4+ and CD3+CD8+ spleen
cells on days 3, 9, 15, 21, and 27 PI while neither subset of T-cells was
identiﬁed in the BST on day 5 or 7 PI (data not shown). Viral titers
were determined in the lip, TG, and throughout the brain every three
days until day 30 PI (Fig. 5). Despite the depletion of both subsets of
T-cells, the spread of HSV-1 in the brains of BL/6 mice remained
restricted to the BST.
In the lip, viral titers were increased ∼100-fold and in the TG ∼10-
fold but not in the BST of depleted mice compared with controls.
Further, HSV-1 was not cleared and infectious virus persisted in the
lip, TG, and BST for at least 30 days PI. Despite this, mice did not
become ill or succumb to infection. These results are comparable with
earlier reports of viral persistence in the foot-pad for at least 15 days
(Smith et al., 1994) and in the TG for at least 35 days (Ghiasi et al.,
1999) in CD4+/CD8+ T-cell depleted BL/6 mice. HSV-1 persistence
was also reported in the TG of BALB/c mice in the absence of TCRαβ+
T-cells, but here virus did spread throughout the brain, resulting in
lethal encephalitis (Sciammas et al., 1997).
Together the results indicate that redundancy in the immune
system plays a role in the clearance of virus from the lip, TG, and BST
and is mediated by CD4+ and CD8+ T-cells. Despite this, HSV-1
remained restricted to the BST of BL/6 mice suggesting that other
immune mechanisms are important in restricting the spread of virus
in the brain.
HSV-1 spreads throughout the CNS of BL/6 CL I KO mice, BL/6 mice treated
with anti-asialoGM1 Ab, and BL/6 mice treated with both anti-CD8 and
anti-NK1.1 mAbs, but not in B6.CD1d−/− KO mice treated with anti-CD8
mAb
Initially, CD8 depleted BL/6 mice and BL/6 CL I KO mice were
infected with a sub-lethal dose of virus to determine if CD8+ T-cells
restrict the spread of HSV-1 in the CNS. Although virus remained
restricted to the BST in CD8 depleted BL/6 mice, surprisingly, HSV-1
spread throughout the brains of ten to twelve week ♀ B6.CL I KO
(B6.129P2-β2mtm1Unc/J) mice before being cleared (Fig 6A). Thisoth anti-CD8 and anti-CD4mAb and infected with a sub-lethal dose of HSV-1 via the oral
time point. Error bars represent SEM.
Fig. 6. Analysis of viral titers throughout the brain of 10–12 week ♀ B6.129P2-B2mtm1unc/J (B6.CL I KO) (A), BL/6 mice treated with anti-asialoGM1 Ab (B), BL/6 mice treated with
both anti-CD8 and anti-NK1.1 mAbs (C), and BL/6 CD1d-deﬁcient (B6.CD1d−/− KO) mice treated with anti-CD8 mAb (D) and infected with a sub-lethal dose of HSV-1 via the oral
mucosa. The ﬁgure represents the results of ﬁve independent experiments; no.=10 mice/time point. *, Pb0.05 by unpaired two-tailed t test. Error bars represent SEM.
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also play a role in restricting the spread of HSV-1 in the CNS. In the KO
mice, viral titers in the lip were similar to controls on day 1 PI but
increased signiﬁcantly by day 3 PI (∼1000-fold). Viral titers also
increased in the TG by day 3 (∼100-fold) and 6 PI as well as in the BST.
HSV-1 was ﬁrst identiﬁed in the CB/CR after day 3 PI; with titers
peaking by day 6/9 PI. Although infectious virus was cleared from all
sites by day 12 PI, it was delayed in the lip, TG, and BST compared to
controls.
To further investigate the possibility of redundancy, BL/6 mice
were treated with anti-asialoGM1 Ab prior to being infected with a
sub-lethal dose of HSV-1 via the oral mucosa. In ten to twelve week ♀
BL/6 mice, given a total of 120 μl of Ab, viral titers were determined in
the lip, TG, and throughout the brain until day 15 PI (Fig. 6B). Viral
titers in the lip were similar to controls on day 1 PI but increased
signiﬁcantly by day 3 PI (∼1000-fold). Viral titers increased in the TG
by day 3 (∼100-fold) and 6 PI. In the BST, titers were maximal on day
9 PI. HSV-1 was ﬁrst identiﬁed in the CB/CR after day 3 PI with titers
peaking by day 6/9 PI. Although infectious virus was cleared from all
sites by day 12 PI, it was delayed in the lip, TG, and BST compared to
controls.
BL/6mice were then treated with anti-CD8+ and anti-NK1.1mAbs
prior to being infected with a sub-lethal dose of HSV-1 via the oral
mucosa. Ten to 12 week ♀ BL/6 mice, given a total of 600 μg of PK136
and 600 μg of 2.43 mAbs, were infected with a sub-lethal dose of
HSV-1. The reduction of CD3−NK1.1+ and CD3+CD8+ cells in the
spleen was similar to that of single depletion studies and neither
population of cells was identiﬁed in the BST on day 5 or 7 PI (data not
shown). Viral titers were determined in the lip, TG, and throughout
the brain until day 15 PI (Fig. 6C). Viral titers in the lip were similar to
controls on day 1 PI but increased signiﬁcantly by day 3 PI (∼1000-
fold). Viral titers also increased in the TG on day 3 (∼100-fold) and 6PI. In the BST, titers peaked by day 8 PI. HSV-1 was ﬁrst identiﬁed
in the CB/CR after day 3 PI and peaked by day 7/8 PI. Although
infectious virus was cleared from all sites by day 9 PI, it was delayed
in the lip, TG, and BST compared to controls.
In ten to 12 week ♀ BL/6 CD1d-deﬁcient (B6.CD1d−/− KO) mice,
given a total of 600 μg of 2.43 mAb, viral titers were determined in the
lip, TG, and throughout the brain until day 15 PI (Fig. 6D). The spread
of virus remained restricted to the BST. Viral titers in the lip were
similar to controls on day 1 PI but increased by days 3 (∼10-fold) and
6 (∼100-fold) PI. Viral titers were also increased in the TG by days 3
(∼100-fold) and 6 PI. In the BST, viral titers were not signiﬁcantly
different from controls.
Together the results indicate that redundancy in the immune
system is important in restricting the spread of HSV-1 in the CNS
of BL/6 mice. Further, our results argue that it is mediated by CD8+
T-cells and NK/NKT cells but not iNKT cells.
Discussion
Herpes simplex virus type 1 (HSV-1) is a ubiquitous human
pathogen (Whitley et al., 1998) that can induce acute and latent
infections of the peripheral and central nervous systems (PNS and
CNS) (Gilden et al., 2001; Baringer and Pisani, 1994), and cause a
number of serious clinical syndromes including neonatal herpetic
infection and HSV-1 encephalitis (Whitley, 2001; Arduino and Porter,
2008). In response to HSV-1 infection, a complex immune cascade is
triggered that involves both the innate and adaptive immune systems
(Nash and Cambouropoulos, 1993; Borysiewicz and Sissons, 1994;
Mossman, 2002; Khanna et al., 2004). Although HSV-1 infection in
experimental animals has increased our knowledge of the immune
response at the primary site of infection and in the PNS (Roizman and
Knipe, 2001; Bloom, 2006; Pack and Rouse, 2006), the immune
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objective of this study was to identify the role of cellular immunity in
mediating resistance to HSV-1 encephalitis following infection of the
oral mucosa, the results are also relevant to the immune response to
viral replication and clearance at the primary site of infection and in
the PNS.
Following infection of the oral mucosa with a sub-lethal dose of
HSV-1, virus reaches the TG of susceptible BALB/c and resistant BL/6
mice simultaneously but titers are signiﬁcantly increased in the
susceptible strain. The results are consistent with those of Simmons
(1989) who reported viral titers in peripheral ganglia to be mouse
strain dependent but contrast with those of Simmons and LaVista
(1989) who reported a delay in virus reaching the peripheral ganglia
in resistant strains. Similarly, infection of the oral mucosa with HSV-1
results in a signiﬁcant increase in viral titers in the BST of BALB/c
compared to BL/6 mice. This is in contrast to the studies of Lundberg
et al. (2003, 2007) where, following corneal scariﬁcation, signiﬁcant
differences in HSV-1 titers in the BST were not identiﬁed in resistant
BL/6 compared to susceptible 129S6 mice. Although viral titers in the
TG or BST could not be used as a surrogate marker for mortality in
their model, differences in viral titers in the TG and BST of BL/6 and
BALB/c mice correlate with resistance to mortality in these strains
after infection of the oral mucosa (Kastrukoff et al., 1986) and allows
viral titers to be used as a surrogate marker in this model.
Cellular immunity can contribute to the restriction of viral
replication at the primary site of infection and in the PNS (Table 1).
The contribution of NK cells remains controversial with some studies
supporting their role (Brandt and Salkowski, 1992; Habu et al., 1984;
Lopez et al., 1980, 1983; Pereira et al., 2001; Rager-Zisman et al., 1987)
while others do not (Bukowski and Welsh, 1986; Chmielarczyk et al.,
1983; Rossol-Voth et al., 1991). Similarly, iNKT cells are reported to
play a role by some investigators (Grubor-Bauk et al., 2003) but not
others (Cornish et al., 2006). In mice infected with HSV-1 via the oral
mucosa, results from depletion studies support a role for NK/NKT cells
in restricting viral replication in the lip and TG during early stages
of infection. Similar results were obtained by Reading et al. (2006) in
BL/6 mice depleted of NK cells and infected intranasally but not by
Kassim et al. (2009) in mice infected in the foot-pad. These results
raise the possibility that NK/NKT cells may play a role in mucosal
but not skin infections with HSV-1. In contrast, our results support
only a modest effect of iNKT cells and no effect by γδ T-cells in
restricting viral replication in the lip and TG. Although both CD4+ and
CD8+ T-cells are reported to contribute to the control of primary HSV-
1 infection (Carr and Tomanek, 2006), it is generally agreed that either
T-cell subset can control infection in the periphery while CD8+ T-cellsTable 1
Role of cellular immunity in restricting HSV-1 replication and clearance.
Oral mucosa Trigeminal ganglia
(PNS)
Brainstem
(CNS)
Restriction of viral replication
NK/NKT cells +++a ++a –
iNKT cells +a +a –
γδ T-cells – – –
CD8+ T-cells ++b ++b –
CD4+ T-cells ++b – –
CD8+ and CD4+ T-cells ++b + –
Viral clearance
NK/NKT cells – – –
iNKT cells – – –
γδ T-cells – D –
CD8+ T-cells – D –
CD4+ T-cells D D –
CD8+ and CD4+ T-cells NC NC NC
Depletion results in+++=1000 fold;++=100 fold;+=10 fold increase inviral titers.
D = delay in viral clearance; NC = virus is not cleared and persists for N30 days.
a Day 3 PI.
b Day 6 PI.control infection in the peripheral ganglia (Pack and Rouse, 2006). In
mice infected with HSV-1 via the oral mucosa, results from both
depletion studies and KOmice support roles for both subsets of T-cells
in restricting viral replication in the lip during later stages of infection.
Our results also support the observation that CD4+ T-cells do not
contribute signiﬁcantly to the restriction of viral replication in the
peripheral ganglia but rather this is mediated by CD8+ T-cells.
Cellular immunity also plays a role in the clearance of infectious
HSV-1 from the lip, TG, and BST after infection of the oral mucosa
(Table 1). In both HSV-1 infected BALB/c and BL/6 mice, virus is
cleared from all sites by day 9 PI. In BL/6 mice, the clearance of
infectious virus from the lip is similar to that of the foot-pad (Smith
et al., 1994) and skin (Simmons and Tscharke, 1992) while clearance
from the peripheral ganglia after infection of the oral mucosa, is
similar to that following other routes of inoculation (Bonneau and
Jennings, 1989; Cantin et al., 1999a,b; Liu et al., 1996, 2000; Simmons
and Tscharke, 1992; Smith et al., 1994). Individually, NK/NKT, iNKT,
γδ T-cells, CD4+, and CD8+ T-cells are not essential for the clearance
of infectious virus from the lip, TG, or BST as virus is cleared despite
the depletion of these immune cell subsets. However, the depletion of
these subsets can affect the kinetics of viral clearance. There is a delay
in the clearance of virus from the lip and TG of CD4+ T-cell depleted
BL/6 and BL/6 CL II KO mice. Although previously reported, the delay
was unexplained (Ghiasi et al., 1999). One possible explanation
involves the lack of CD4+ T-cell help to effector CD8+ CTL and B-cells
(Iijima et al., 2008). While many viruses generate CD8+ CTL in the
absence of helper cells (Mintern et al., 2002; Smith et al., 2004), the
need for CD4+ T-cell help in the development of anti-HSV CD8+ CTL
remains unclear (Behrens et al., 2004). The need for T-cell help has
been reported by some (Jennings et al., 1991; Smith et al., 2004) but
not others (Vasilakos and Michael, 1993) while still others suggest
that help may only be required by speciﬁc mouse strains (Mercadal
et al., 1991). Recently, the lack of CD4+ T-cells was shown to be
associated with a partial rescue of dysfunctional CD8+ CTL by NK cells
(Nandakumar et al., 2008) and may explain, in part, the observed
delay in viral clearance. Clearance of virus from the TG is also delayed
in BL/6 γδ T-cell KO mice and BL/6 mice depleted of CD8+ T-cells
or BL/6 CD8 KO mice. This is consistent with the time required to
activate virus speciﬁc CD8+ T-cells (Coles et al., 2002) and to localize
to the site of inﬂammation (van Lint et al., 2005). A similar effect was
observed in zosteriform (van Lint et al., 2004) and corneal (Land and
Nikolich-Zugich, 2005) models. Our results do support a role for
redundancy in the immune system in clearing HSV-1 from the lip, TG,
and BST. Although virus is cleared from all three sites in HSV-1
infected BL/6 mice depleted of either CD4+ or CD8+ T-cells, HSV-1
persists when both T-cell subsets are depleted. In these mice, virus
persists for at least 30 days PI. Similar results have been reported by
some (Ghiasi et al., 1999; Smith et al., 1994) but not all investigators
(Reading et al., 2006).
Resistance to HSV-1 encephalitis is genetically complex and
involves multiple interacting loci (Lundberg et al., 2008). As a result,
it has been difﬁcult to identify mechanisms contributing to resistance
although TNF has been determined to play an important role
(Lundberg et al., 2007). After infection of the oral mucosa, HSV-1
was identiﬁed throughout the brains of mice either dying or near
death from viral encephalitis (Kastrukoff et al., 1986, 1993). This led
us to hypothesize that lethal HSV-1 encephalitis results from the
inability of the host to restrict the spread of virus, to control viral
replication, or to clear virus from the CNS. Further, we reasoned that it
might be possible to identify mechanisms mediating resistance to
encephalitis by using a sub-lethal dose of HSV-1.
This study identiﬁes two mechanisms in different mouse strains
that likely contribute to resistance to HSV-1 encephalitis following
infection of the oral mucosa. In BL/6mice, virus is restricted to the BST
while in BALB/c mice, HSV-1 spreads throughout the brain but is then
cleared without mortality. Support for the second mechanism comes
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spreads throughout the brain with viral titers reaching levels
identiﬁed in BALB/c mice. However, unlike BALB/c mice, infectious
virus in the brains of the KO mice is not cleared and all mice succumb
to lethal encephalitis within 12 days PI. Further, results from HSV-1
infected B6.RAG-1−/− KO mice indicate that both restriction of
viral spread and viral clearance in the brains are immune mediated.
These results contrast with those of Lundberg et al. (2003, 2007)
where lethal encephalitis correlates with the extent and nature of the
inﬂammation in the BST rather than viral titers (Lundberg et al.,
2008). It is likely that different mechanisms mediate resistance to
mortality in different models of HSV-1 encephalitis. Further, the
results underscore the complexity of mortality as an outcome mea-
sure in the different models of lethal HSV-1 encephalitis.
Redundancy in the immune system is recognized to play an
important role in a number of viral infections including HSV-1. In this
study, we used a combination of antibody depleted and KO mice to
examine the role of cellular immunity in restricting the spread of HSV-1
in the brains of BL/6mice. Results from these studies indicate that CD4+
and CD8+ T-cells alone do not restrict the spread of HSV-1. The spread
of HSV-1 is also restricted in B6.CD1d−/−, B6.TCRJα281, and B6.129P2-
Tcrdtm1Mom/J mice indicating that NKT and γδ T-cells are not critical to
the restriction of viral spread. Further, HSV-1 remains restricted in BL/6
mice depleted of NK/NKT cells or both CD4+ and CD8+ T-cells. In
contrast, HSV-1 does spread throughout the brain of BL/6 CL I KO mice
and raised the possibility that redundancy in the immune system may
play a role in restricting viral spread. In β2mtm1Unc mutant mice (Koller
et al., 1990), conventional CD8+ T-cells (Zijlstra et al., 1990) and iNKT
cells (Adachi et al., 1995) are signiﬁcantly depleted. Further, although
NK cell numbers are normal (Raulet, 1994) in thesemice, their function
may be impaired (Raulet and Vance, 2006; Yokoyama and Kim, 2006).
Less likely, the spread of virus in the brains of these KOmice could result
from a linkedﬂanking gene rather than a CL I effect (Wolfer et al., 2002).
To further examine the possibility of redundancy, BL/6 mice were
treated with anti-asialoGM1 Ab and infected with HSV-1. Wuest and
Carr (2008) reported that BL/6 mice, treated with anti-asialoGM1 Ab
and infected with HSV-1 via ocular scariﬁcation, were depleted of NK
cells and HSV speciﬁc CD8+ T-cells, but not other immune cells. We
also observed a similar effect of anti-asialoGM1AbonNKcells andCD8+
T-cells in BL/6mice infectedwithHSV-1 via the oralmucosa (Kastrukoff
et al., 2004). In these mice, virus is no longer restricted to the BST and
spreads throughout the brain before being cleared. Similarly, HSV-1
spreads throughout the brain of infected BL/6 mice treated with both
anti-NK1.1 and anti-CD8 mAbs. The results from three independent
studies converge and argue that redundancy in the immune system,
mediated by NK/NKT and CD8+ T-cells, contributes to the restriction of
HSV-1 spread in the brains of BL/6 mice. The failure of HSV-1 to spread
throughout the brains of B6.CD1d−/− KO mice treated with anti-CD8
mAb makes it unlikely that iNKT cells contribute to the restriction of
HSV-1 spread in the brains of BL/6 mice but cannot entirely exclude a
role for other NKT cell such as mNKT (Treiner et al., 2003). Support for
NK cells and CD8+ T-cells being responsible for restricting the spread of
HSV-1 in the brain comes from the studies of Wuest and Carr (2008).
Using ﬂow cytometric analysis, they identiﬁed, among others, the pres-
ence of NK cells and CD8+ T-cells, but not NKT cells in the TG and BST
of BL/6mice infected with HSV-1 via the trigeminal nerve. Results from
our ﬂow cytometric studies conﬁrm their observations.
Materials and methods
Mice
Eight to ten week old ♀ C57BL/6, BALB/c, B6.129S7-Rag1tm1Mom/J
(B6. RAG-1−/− KO) (10th generation backcross to BL/6), B6.129P2-
Tcrdtm1Mom/J (12thgenerationbackcross toBL/6),B6.129S2-Cd8atm1Mak/J
(B6.CD8 KO) (13th generation backcross to BL/6), B6.129-H2d1Ab1-Ea/J(B6.CL II KO) (12th generation backcross to BL/6), and B6.129P2-
B2mtm1unc/J (B6. CL I KO) (11th generation backcross to BL/6) mice
were purchased from Jackson Laboratories and used at ten to twelve
weeks of age. Breeding pairs of C57BL/6 CD1d-deﬁcient (B6.CD1d−/−)
and C57BL/6 NKT cell-deﬁcient (B6.TCR Jα281 KO) mice were kindly
provided by Dr. Mark Smyth (Melbourne, Au). Both CD1d-deﬁcient and
NKT cell-deﬁcient mice were backcrossed to BL/6 mice for 10
generations. All mice were housed under speciﬁc pathogen-free
conditions in animal facilities, Faculty of Medicine, University of British
Columbia. All investigations followed the guidelines of the Institutional
Animal Care and Use Committee of the University of British Columbia.
Virus and cells
HSV-1 (lab strain 2) was grown on BHK-21 cells and viral titers
determined by plaque assay (Kastrukoff et al., 1982). HSV-1, lab strain
2, was originally isolated from human trigeminal ganglia (TG), plaque
puriﬁed, and characterized by Dr. Moira Brown (Institute for Virology,
Glasgow) (Kastrukoff et al., 1981, 1982). Similar to i.p. challenge
(Lopez, 1975), natural resistance to mortality following inoculation of
the oral mucosa with this strain of HSV-1 is a dominant autosomal
trait and dependent on the inbred mouse strain (Kastrukoff et al.,
1986). Further, inoculation with a sub-lethal dose of this strain results
in the development of virus induced CNS demyelination in susceptible
inbred strains of mice (Kastrukoff et al., 1987, 1992). Virus was stored
at−80 °C until required. The oral mucosa was inoculated with 2×105
PFU of virus using a scariﬁcation method described previously
(Kastrukoff et al., 1986).
Viral titers
Viral titers of HSV-1 in the lip, TG, BST, CB, and CRwere determined
as previously described (Kastrukoff et al., 1986). Brieﬂy, mice were
sacriﬁced at speciﬁc intervals PI. A craniotomy was performed and
incisions made to separate the cervical spinal cord from the
brainstem, the midbrain from the cerebral hemispheres, the brain-
stem from the cerebellum, and the cerebral hemispheres from each
other. Tissue was freeze-thawed three times and disrupted with a
Ten Broeck homogenizer prior to centrifugation. Serial dilutions of
the supernatant were plaque-assayed on CV1 cells as previously
described (Kastrukoff et al., 1986).
Antibodies
Anti-NK1.1 (PK136), anti-CD4 (GK 1.5), and anti-CD8 (2.43) mAb
were purchased from the National Cell Culture Center (Minneapolis,
MN) and used in cell depletion studies.
NK/NKT cell depletion using anti-NK1.1 (PK136) mAb
Ten to 12 week old♀ BL/6micewere treatedwith anti-NK1.1mAb
(Koo and Peppard, 1984; Koo et al., 1986; Wang et al., 1998). Two
hundred μg of PK136 mAb was given i.p. on days−2, 0, and +7. The
optimal amount of mAb for the total in-vivo depletion of NK cells on
days +1 and +7 had previously been determined by a functional
assay using 51Cr labeled YAC-1 target cells (Kastrukoff et al., 2004) and
is consistent with other investigators (Muhlen et al., 2004; Kassim
et al., 2009). Control mice received equivalent amounts of puriﬁed rat
IgG. Viral titers were determined in the lip, TG, BST, CB, and CR in ten
mice per day from day 1 through 6 PI as well as days 9, 12, and 15 PI.
CD4+ and/or CD8+ T-cell depletion using anti-CD4 (GK 1.5) and/or
anti-CD8 (2.43)
Ten to 12 week old ♀ BL/6 mice were treated with either GK1.5,
2.43, or both mAbs (Ghiasi et al., 1999). One hundred μg of either mAb
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each of anti-CD4 and anti-CD8 was given on days −4, −1, +2, +5,
+11, +17, and +23. Control mice received equivalent amounts of
puriﬁed rat IgG.
NK/NKT and CD8+ T-cell depletion using anti-asialoGM1 Ab
Ten to 12 week old ♀ BL/6 mice were treated with anti-asialoGM1
Ab (Wako Chemicals) (Smyth et al., 2001). Forty μl of anti-asialoGM1
Abwas given i.p. on days−1, 0, and+7. The optimal amount of Ab for
the total in-vivo depletion of NK cell functional activity on days +1
and +7 had previously been determined using 51Cr labeled YAC-1
target cells and by phenotypic analysis using ﬂow cytometry. Simi-
larly, the optimal amount of Ab for the in-vivo depletion of gB498–505
speciﬁc CTL in draining cervical lymph nodes on day +5 was deter-
mined by a 4 h 51Cr release assay using EL4 cells pulsed with gB498–505
as target cells (Kastrukoff et al., 2004). The amount of Ab required is
consistent with other investigators (Wuest and Carr, 2008). Control
animals received equivalent amounts of puriﬁed rat IgG. Viral titers
were determined in the lip, TG, BST, CB, and CR in ten mice per day
on days 1, 3, 6, 9, 12, and 15 PI.
NK/NKT and CD8+ T-cell depletion using anti-NK1.1 (PK136) and
anti-CD8 (2.43) mAbs
Ten to 12 week old♀ BL/6mice were treatedwith both anti-NK1.1
and anti-CD8 mAbs. Two hundred μg of PK136 mAb was given i.p. on
days −2, 0, and +7 while 100 μg of 2.43 mAb was given i.p. on days
−4, −1, +2, +5, +11, and +14. Control mice received equivalent
amounts of puriﬁed rat IgG. Viral titers were determined in the lip, TG,
BST, CB, and CR in ten mice per day on days 1, 3, 6, 7, 8, 9, 12 and 15 PI.
CD8+ T-cell depletion in BL/6 CD1d−/− KO mice with anti-CD8 (2.43)
mAb
Ten to twelve week old ♀ BL/6 CD1d-deﬁcient (B6.CD1d−/− KO)
mice were treated with 100 μg of 2.43 mAb given i.p. on days−4,−1,
+2, +5, +11, and +14 (Chen et al., 1997; Smiley et al., 1997).
Control mice received equivalent amounts of puriﬁed rat IgG. Viral
titers were determined in the lip, TG, BST, CB, and CR in ten mice per
day from days 1, 3, 6, 9, 12, and 15 PI.
Flow cytometry
Surface markers were analyzed using anti-mouse anti-CD3ε (145-
2C11), anti-CD4 (RM4-4), anti-CD8 (C53.6.7), anti-NK1.1 (PK136),
and anti-CD45 conjugated with APC, FITC, or PE (BD Pharmingen).
Single cell suspensions of spleen cells from two mice were
obtained from day 3 through 27 PI followed by osmotic lysis of
erythrocytes using a NH4CL solution (Sigma-Aldrich). Viability counts
were performed in trypan blue.
In some studies, TG and BST were obtained and pooled from ﬁve
mice sacriﬁced on day 3, 5, or 7 PI. Tissues were disrupted with a Ten
Broeck homogenizer (Fischer Scientiﬁc) and the suspension passed
through a 70 μm nylon cell strainer.
Samples were blocked with 2 μl of Fc Block anti-mouse CD16/32
(BD Pharmingen) and incubated for 20 min on ice. Two μl of rat serum
was added for a further incubation of 20 min. Solutions of (1:100
dilution) anti-CD3ε, anti-CD4, anti-CD8, or anti-NK1.1 were added as
well as anti-mouse CD45 and incubated for 30 min on ice. Cells were
labeled with anti-CD3ε and anti-NK1.1, anti-CD3ε and anti-CD4
(RM4-4), anti-CD3ε and anti-CD8 (C54.6.7) or anti-CD3ε and both
anti-CD4 and anti-CD8. The RM4-4 clone was previously determined
not to cross react with GK1.5 while the C53.6.7 clone was determined
not to react with 2.43 (unpublished results). Cells were washed three
times with 1.0% BSA in 1× PBS. The single cell suspensions were ﬁxedovernight in 1.0% paraformaldehyde, and resuspended in 1.0% BSA in
PBS for analysis on a FACSCaliber (BD Biosciences). Analysis of cells
obtained from TG and BST followed the method of Wuest and Carr
(2008) with events gated by forward and side scatter as well as by
high expression of CD45 Ag.
Statistics
All analyses for statistically signiﬁcant differences were performed
with Student's unpaired two-tailed t test. Pb0.05 is considered sig-
niﬁcant. Results are expressed as mean±SEM.
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